DiscoverMoneycontrol Podcast3053: Coronavirus Essential | Oxford vaccine has an average 70% efficacy; US, Europe may begin vaccinations by mid-December
3053: Coronavirus Essential | Oxford vaccine has an average 70% efficacy; US, Europe may begin vaccinations by mid-December

3053: Coronavirus Essential | Oxford vaccine has an average 70% efficacy; US, Europe may begin vaccinations by mid-December

Update: 2020-11-23
Share

Description

Tune in to Coronavirus Essential podcast with Sakshi Batra for all the news on the pandemic.
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

3053: Coronavirus Essential | Oxford vaccine has an average 70% efficacy; US, Europe may begin vaccinations by mid-December

3053: Coronavirus Essential | Oxford vaccine has an average 70% efficacy; US, Europe may begin vaccinations by mid-December

moneycontrol